 |
 |
 |
 |
 |
 |
|
||||||||||||||
CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY — Dr Morrow had no real or apparent conflicts of interest to disclose. The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Prof Smith — Advisory Committee: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Roche Laboratories Inc, Sanofi-Aventis; Lecturing: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline; Speakers Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Carlson — Advisory Committee: Genomic Health Inc; Consulting Agreements: AstraZeneca Pharmaceuticals LP, Pfizer Inc; Paid Research: AstraZeneca Pharmaceuticals LP, Genentech BioOncology. Dr Paik — Advisory Committee: Genentech BioOncology, GlaxoSmithKline.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.
| Table of Contents | Top of Page |
INTERVIEWS
Neil Love, MD
Editor
Monica Morrow, MD
- Select publications
Ian E Smith, MD
- Select publications
Robert W Carlson, MD
- Select publications
Soonmyung Paik, MD
- Select publications
Breast Cancer Update
for Surgeons:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
